Reuters - Video

Edition: US | UK | IN | CN | JP

video Business

Breakingviews TV: Pill popping

Friday, November 01, 2019 - 03:21

Nov 1 - Pharma giant Amgen is buying a fifth of China biotech star BeiGene for $2.7 bln. A 36% premium seems steep when the target has just shaken off a short-seller attack. But it’s a chance to crack a growing market for cancer drugs, Katrina Hamlin tells Pete Sweeney.

▲ Hide Transcript

View Transcript

Nov 1 - Pharma giant Amgen is buying a fifth of China biotech star BeiGene for $2.7 bln. A 36% premium seems steep when the target has just shaken off a short-seller attack. But it’s a chance to crack a growing market for cancer drugs, Katrina Hamlin tells Pete Sweeney.

Press CTRL+C (Windows), CMD+C (Mac), or long-press the URL below on your mobile device to copy the code

Breakingviews TV: Pill popping

Friday, November 01, 2019 - 03:21